Skip to main content
PET Imaging with Prostate-Specific Membrane Antigen for Prostate Cancer: Clinical Utility
( Last Updated : November 26, 2020)
Project Sub Line:
Summary of Abstracts
- What is the clinical utility of positron emission tomography (PET) imaging using prostate-specific membrane antigen (PSMA) labelled with gallium-68 (Ga-68) or fluorine-18 (F-18) in patients with suspected or confirmed metastatic or biochemically recurrent prostate cancer?